Abstract:Studies have shown that Annexin A2 (ANXA2) is related with tumor proliferation, apoptosis, differentiation, invasion, migration, and drug resistance. The purpose of this study was to investigate the role and its mechanisms of ANXA2 in multi-drug-resistance (MDR) in gastric cancer. ANXA2 expression in both gastric cancer tissues and cell lines were detected by quantitative real-time PCR (RT-qPCR) and Western blotting. The cell proliferation was measured by SRB assay. The pool of siRNA against ANXA2 was designed and synthesized and then transfected into resistant gastric cancer SGC7901/DDP cells. ANXA2 expression was detected by RT-qPCR and Western blotting. Drug sensitivities of SGC7901/DDP cells to P-gp-related drug (doxorubicin) and P-gp-non-related drugs (5-FU and cisplatin) were measured by SRB assay. Expression of MDR-related genes and phosphorylation of AKT and MAPKs were also detected by RT-qPCR and Western blotting. Results showed that ANXA2 expression was significantly higher in gastric specimens than that in normal tissues, and negatively correlated with the differentiation level of gastric cancer. In addition, ANXA2 expression level was higher in SGC7901/DDP cells than that in parent SGC7901 cells. After knock-down ANXA2 expression using ANXA2 small interfering RNA, the drug sensitivity of SGC7901/DDP cells to doxorubicin, 5-FU and DDP increased. Delivery of ANXA2 siRNA significantly downregulated the expression of P-gp, MRP1 and Bcl-2, while markedly upregulated Bax in SGC7901/DDP cells. However, several other MDR factors such as GST-π, TOPO-I and TOPO-II had no obvious changes. Additionally, phosphorylation of P38MAPK and AKT, but not ERK1/2 or JNKs was specifically decreased in SGC7901/DDP cells after ANXA2 siRNA delivery. Importantly, P38MAPK and AKT inhibitor increased the drug sensitivity of SGC701/DDP cells in a similar way as ANXA2 siRNAs does. ANXA2 is involved in gastric cancer MDR through regulating p38MAPK and AKT pathways as well as certain MDR factors.

Up‐regulation ofAnxa2gene promotes proliferation and invasion of breast cancerMCF‐7 cells

Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells.

Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells

Crucial Role of Anxa2 in Cancer Progression: Highlights on Its Novel Regulatory Mechanism

Tyr23 Phosphorylation of Anxa2 Enhances STAT3 Activation and Promotes Proliferation and Invasion of Breast Cancer Cells

P-glycoprotein Associates with Anxa2 and Promotes Invasion in Multidrug Resistant Breast Cancer Cells

Rnai-Mediated Silencing of Anxa2 Inhibits Breast Cancer Cell Proliferation by Downregulating Cyclin D1 in Stat3-Dependent Pathway

Annexin A2 Promotes the Migration and Invasion of Human Hepatocellular Carcinoma Cells in Vitro by Regulating the Shedding of CD147-Harboring Microvesicles from Tumor Cells

Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements

A Novel Anxa2-interacting Protein Ebp1 Inhibits Cancer Proliferation and Invasion by Suppressing Anxa2 Protein Level

Tyrosine 23 Phosphorylation of Annexin A2 Promotes Proliferation, Invasion, and Stat3 Phosphorylation in the Nucleus of Human Breast Cancer SK-BR-3 Cells.

Annexin A1 Regulates TGF-beta Signaling and Promotes Metastasis Formation of Basal-Like Breast Cancer Cells.

ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells

Annexin A2 is Implicated in Multi-Drug-resistance in Gastric Cancer Through P38mapk and AKT Pathway.

Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin

Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer

Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers

ANXA1 enhances tumor proliferation and migration by regulating epithelial-mesenchymal transition and IL-6/JAK2/STAT3 pathway in papillary thyroid carcinoma

Effect of the Interaction Between Anxa2 and P-gp on Migration and Invasion of Multidrug Resistant Human Breast Cancer Cells

Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2

ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway